This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Cogan, J. J. Articles by Rapaport, E. Search for Related Content PubMed PubMed Citation Articles by Cogan, J. J. Articles by Rapaport, E.

Circulation, Vol 64, 973-976, Copyright © 1981 by American Heart Association

ARTICLES

Acute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure

JJ Cogan, MH Humphreys, CJ Carlson, NL Benowitz and E Rapaport

We studied the effect of vasodilator therapy on renal digoxin clearance in patients with chronic congestive heart failure. Intravenous administration of nitroprusside or hydralazine to eight patients with severe heart failure produced the expected increase in cardiac output and a decrease in central circulatory pressure. Renal clearance of sodium para-aminohippurate and estimated renal blood flow increased without a change in glomerular filtration rate. Total renal clearance of digoxin increased by 50% during vasodilator therapy. Thus, acute administration of vasodilator increases renal digoxin clearance without changing glomerular filtration rate, suggesting an increase in tubular secretion of digoxin. Long-term vasodilator therapy may alter the maintenance dosage of digoxin required for optimal treatment of patients in congestive heart failure.